-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, Hebei has implemented an innovation-driven development strategy, and the pharmaceutical industry has shown a vigorous development tre.
Data show that in the first half of this year, the industrial added value of the pharmaceutical manufacturing industry above designated size in Hebei increased by 13% year-on-year, which was 11 percentage points higher than the province's industrial avera.
Among them, in June, the industrial added value of the pharmaceutical manufacturing industry above designated size in Hebei increased by 21% year-on-ye.
In terms of operating income, in the first half of this year, 415 enterprises in the pharmaceutical industry above designated size in Hebei achieved a year-on-year increase of 8% in operating income, reaching 5823 billion yu.
In terms of profit, in the first half of this year, the total profit of the pharmaceutical industry above designated size in Hebei increased by 4% year-on-year, reaching 876 billion yu.
From the perspective of subdivisions, in the first half of the year, pharmaceutical excipients and packaging materials grew faster in Hebei's pharmaceutical industry, with a year-on-year increase of 74%; pharmaceutical special equipment increased by 35% year-on-ye.
Chemical raw materials contributed a lot to the industry, with a contribution rate of 42%, driving the industry to grow by 4 percentage poin.
In the first half of the year, the profit of pharmaceutical excipients and packaging materials increased by 509% year-on-year; the profit of Chinese patent medicine production increased by 57% year-on-year; the profit of chemical raw materials increased by 43% year-on-ye.
Among them, the production of Chinese patent medicines has made a great contribution to the industry in terms of profits, driving the industry to grow by 5 percentage poin.
It is understood that in recent years, in the development of the pharmaceutical industry, Hebei has been continuously focusing on the major scientific and technological needs of the pharmaceutical industry to supplement, strengthen and extend the cha.
Promote the accumulation of innovative elements such as funds, projects and platforms in the pharmaceutical industry, and promote key technological breakthroughs in the pharmaceutical indust.
Data show that in the first half of this year, the investment in Hebei pharmaceutical industry increased by 14% year-on-year, of which investment in industrial technological transformation increased by 46% year-on-year; the number of projects under construction increased by 11% year-on-year, of which industrial technological transformation projects increased by 46% year-on-ye.
Gathering resources, maintaining integrity and innovation, Hebei's pharmaceutical industry moves forward steadi.
Hebei has established 150 major innovation platforms in the field of biomedicine, and many large pharmaceutical companies have achieved technological breakthroughs, and pharmaceutical innovations have continued to emerge
For example, in 2022, the mitoxantrone liposome drug Doenda independently developed by CSPC's special preparation innovation team was officially launch.
Now, CSPC's R&D team is continuing to make efforts in several major fields such as tumor and neuropsychiat.
Guided by scientific and technological innovation, Yiling Pharmaceutical has produced scientific research achievements one after another, and has successively approved 3 new traditional Chinese medicine drugs in the past two yea.
In order to better promote the development of the pharmaceutical industry, Hebei continues to strengthen the empowerment of talen.
It is reported that as the cradle of cultivating medical talents, colleges and universities in Hebei have built a new paradigm for the cultivation of innovative medical talen.
Hebei's vocational colleges have explored new practice methods for applied medical talen.
In terms of promoting the high-quality development of the pharmaceutical industry, Hebei Province has successively issued innovative reform policies such as "Opinions on Strengthening Drug Safety Work to Promote the Innovative Development of the Pharmaceutical Industry" and "Several Policies and Measures to Support the High-Quality Development of the Pharmaceutical Industr.
Recently, the Hebei Provincial Food and Drug Administration issued a number of measures to further support the high-quality development of the pharmaceutical industry, and put forward 18 specific measures from three aspects: supporting enterprise R&D innovation, optimizing inspection and supervision methods, and improving the efficiency of government services to help market entiti.
Solve difficulties, stabilize the economic operation of the pharmaceutical field in Hebei Province, and promote the high-quality development of the pharmaceutical indust.
Driven by a series of favorable policies, the pharmaceutical industry in Hebei Province has continuously achieved breakthroug.
It is reported that in the past ten years, Hebei Province has obtained a total of 454 drug approval numbe.
In 2021, the operating income of the pharmaceutical industry above designated size in Hebei Province will exceed the 100 billion yuan ma.
In addition, data shows that in the first half of this year, Hebei has also achieved great growth in the output of pharmaceutical industry produc.
In the first half of this year, Hebei achieved a year-on-year increase of 7% in the cumulative production of technical chemicals, reaching 314,100 to.
Among them, in June, the output of chemical raw materials increased by 14% year-on-year to 53,300 tons; the output of Chinese patent medicines increased by 12% year-on-year to 3,400 to.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
Data show that in the first half of this year, the industrial added value of the pharmaceutical manufacturing industry above designated size in Hebei increased by 13% year-on-year, which was 11 percentage points higher than the province's industrial avera.
Among them, in June, the industrial added value of the pharmaceutical manufacturing industry above designated size in Hebei increased by 21% year-on-ye.
In terms of operating income, in the first half of this year, 415 enterprises in the pharmaceutical industry above designated size in Hebei achieved a year-on-year increase of 8% in operating income, reaching 5823 billion yu.
In terms of profit, in the first half of this year, the total profit of the pharmaceutical industry above designated size in Hebei increased by 4% year-on-year, reaching 876 billion yu.
From the perspective of subdivisions, in the first half of the year, pharmaceutical excipients and packaging materials grew faster in Hebei's pharmaceutical industry, with a year-on-year increase of 74%; pharmaceutical special equipment increased by 35% year-on-ye.
Chemical raw materials contributed a lot to the industry, with a contribution rate of 42%, driving the industry to grow by 4 percentage poin.
In the first half of the year, the profit of pharmaceutical excipients and packaging materials increased by 509% year-on-year; the profit of Chinese patent medicine production increased by 57% year-on-year; the profit of chemical raw materials increased by 43% year-on-ye.
Among them, the production of Chinese patent medicines has made a great contribution to the industry in terms of profits, driving the industry to grow by 5 percentage poin.
It is understood that in recent years, in the development of the pharmaceutical industry, Hebei has been continuously focusing on the major scientific and technological needs of the pharmaceutical industry to supplement, strengthen and extend the cha.
Promote the accumulation of innovative elements such as funds, projects and platforms in the pharmaceutical industry, and promote key technological breakthroughs in the pharmaceutical indust.
Data show that in the first half of this year, the investment in Hebei pharmaceutical industry increased by 14% year-on-year, of which investment in industrial technological transformation increased by 46% year-on-year; the number of projects under construction increased by 11% year-on-year, of which industrial technological transformation projects increased by 46% year-on-ye.
Gathering resources, maintaining integrity and innovation, Hebei's pharmaceutical industry moves forward steadi.
Hebei has established 150 major innovation platforms in the field of biomedicine, and many large pharmaceutical companies have achieved technological breakthroughs, and pharmaceutical innovations have continued to emerge
For example, in 2022, the mitoxantrone liposome drug Doenda independently developed by CSPC's special preparation innovation team was officially launch.
Now, CSPC's R&D team is continuing to make efforts in several major fields such as tumor and neuropsychiat.
Guided by scientific and technological innovation, Yiling Pharmaceutical has produced scientific research achievements one after another, and has successively approved 3 new traditional Chinese medicine drugs in the past two yea.
In order to better promote the development of the pharmaceutical industry, Hebei continues to strengthen the empowerment of talen.
It is reported that as the cradle of cultivating medical talents, colleges and universities in Hebei have built a new paradigm for the cultivation of innovative medical talen.
Hebei's vocational colleges have explored new practice methods for applied medical talen.
In terms of promoting the high-quality development of the pharmaceutical industry, Hebei Province has successively issued innovative reform policies such as "Opinions on Strengthening Drug Safety Work to Promote the Innovative Development of the Pharmaceutical Industry" and "Several Policies and Measures to Support the High-Quality Development of the Pharmaceutical Industr.
Recently, the Hebei Provincial Food and Drug Administration issued a number of measures to further support the high-quality development of the pharmaceutical industry, and put forward 18 specific measures from three aspects: supporting enterprise R&D innovation, optimizing inspection and supervision methods, and improving the efficiency of government services to help market entiti.
Solve difficulties, stabilize the economic operation of the pharmaceutical field in Hebei Province, and promote the high-quality development of the pharmaceutical indust.
Driven by a series of favorable policies, the pharmaceutical industry in Hebei Province has continuously achieved breakthroug.
It is reported that in the past ten years, Hebei Province has obtained a total of 454 drug approval numbe.
In 2021, the operating income of the pharmaceutical industry above designated size in Hebei Province will exceed the 100 billion yuan ma.
In addition, data shows that in the first half of this year, Hebei has also achieved great growth in the output of pharmaceutical industry produc.
In the first half of this year, Hebei achieved a year-on-year increase of 7% in the cumulative production of technical chemicals, reaching 314,100 to.
Among them, in June, the output of chemical raw materials increased by 14% year-on-year to 53,300 tons; the output of Chinese patent medicines increased by 12% year-on-year to 3,400 to.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
